Currently out of the existing stock ratings of Rachel Vatnsdal, 6 are a SELL (12.24%), 22 are a HOLD (44.9%), 21 are a BUY (42.86%).

Rachel Vatnsdal

Work Performance Price Targets & Ratings Chart

Analyst Rachel Vatnsdal, currently employed at JPMORGAN, carries an average stock price target met ratio of 55.77% that have a potential upside of 20.42% achieved within 89 days.

Rachel Vatnsdal’s has documented 107 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on NVST, Envista Holdings Corp at 06-Mar-2025.

Wall Street Analyst Rachel Vatnsdal

Analyst best performing recommendations are on TXG (10X GENOMICS).
The best stock recommendation documented was for TXG (10X GENOMICS) at 7/18/2024. The price target of $20 was fulfilled within 8 days with a profit of $3.44 (20.77%) receiving and performance score of 25.97.

Average potential price target upside

AMRS Amyris QDEL Quidel MTD Mettler-Toledo International HSIC Henry Schein DHR Danaher MYGN Myriad Genetics PACB Pacific Biosciences of California PDCO Patterson Companies RGEN Repligen A Agilent Technologies ADPT Adaptive Biotechnologies Corp AKYA Akoya Biosciences ILMN Illumina NVST Envista Holdings Corp TWST Twist Bioscience Corp TXG 10X Genomics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$0.65

$0.51 (364.29%)

$3.35

1 years 10 months 16 days ago
(18-May-2023)

2/2 (100%)

$0.06 (10.17%)

10

Buy

$1.25

$1.2 (2400.00%)

$19

1 years 10 months 24 days ago
(10-May-2023)

3/4 (75%)

$2.13 (47.39%)

21

Buy

$5

$4.86 (3471.43%)

$30

2 years 18 days ago
(16-Mar-2023)

7/10 (70%)

$3.68 (278.79%)

819

Hold

$2

$1.86 (1328.57%)

$2.5

2 years 3 months ago
(03-Jan-2023)

1/2 (50%)

$0.55 (37.93%)

2

Hold

2 years 4 months 25 days ago
(09-Nov-2022)

1/2 (50%)

$7.57 (43.43%)

391

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Rachel Vatnsdal is most bullish on?

Potential upside of $66.59 has been obtained for RGEN (REPLIGEN)

Which stock is Rachel Vatnsdal is most reserved on?

Potential downside of -$0.36 has been obtained for TWST (TWIST BIOSCIENCE CORP)

What Year was the first public recommendation made by Rachel Vatnsdal?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?